Conditions: Atrial Fibrillation Stroke
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 18113
Healthy volunteers: no

Brief summary:
The primary objective of this trial is to demonstrate the efficacy and safety of dabigatran etexilate in patients with non-valvular atrial fibrillation for the prevention of stroke and systemic embolism.

Detailed description:

Arms:
arm 1: twice a day arm 2: once a day arm 3: twice a day

Interventions: intervention 1: warfarin intervention 2: Dabigatran dose 1 intervention 3: Dabigatran dose 2
Intervention descriptions: intervention 1: once a day intervention 2: twice daily intervention 3: twice a day

Protocol document: